Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease
针对潜在的病理生理机制开发慢性阻塞性肺病的新疗法
基本信息
- 批准号:10171619
- 负责人:
- 金额:$ 58.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAffinityAlanineAlveolarAmino AcidsApoptoticAreaArginineAttenuatedBindingBiodistributionBiological AssayCardiacCell Culture TechniquesCell DeathCell DensityCell NucleusCell Surface ProteinsCell surfaceCellsChronicChronic Obstructive Airway DiseaseCiliaCleaved cellCoughingCytolysisDiseaseDisease modelEmbryoEpithelialEpithelial CellsEstersFDA approvedFrequenciesFunctional disorderGenerationsGenus HippocampusGoalsGoblet CellsGrantHairHarvestHeartHigh PrevalenceHospitalizationHumanHyperplasiaImageImpairmentIncubatedInflammatory InfiltrateInhalationInjectionsIntravenousLabelLeadLengthLigandsLower Respiratory Tract InfectionLungMeasuresMitochondriaMitochondrial DNAMorbidity - disease rateMorphologyMucociliary ClearanceMucous body substanceMusNasal EpitheliumOrganOxygenPathway interactionsPeptidesPeripheralPloidiesPopulationPositioning AttributePredispositionProductionProteinsReactive Oxygen SpeciesRecurrenceReduced GlutathioneScanningSerineShortness of BreathSmall Interfering RNAStructure of parenchyma of lungSurfaceTechnologyTestingTherapeuticTimeTissuesTracheobronchialTreesTriceps Brachii MuscleTubulinWorkXenopusairway obstructionbronchial epitheliumburden of illnesscigarette smoke-induced COPDcilium biogenesiscilium motilitycytokinedrug developmentesteraseexposure to cigarette smokefluid flowgamma secretaseimaging systemimprovedin vivoin vivo imaging systeminhibitor/antagonistinterestknock-downmitochondrial dysfunctionmortalitymutantnotch proteinnovelnovel therapeuticspathogenpollutantrecurrent infectionsmall moleculesmoke-induced COPDthioredoxin peroxidasetranscription factoruptakevector
项目摘要
Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction, increased mucus
production, and predisposition to recurrent lower respiratory tract infections. It affects ~5% of the US
population, ranking third as a cause of mortality. This high prevalence and disease chronicity results in
frequent hospitalizations, and need for lifelong therapies. In spite of this high disease burden, there have been
no new FDA approved therapies in the past two decades. Chronic cigarette smoke exposure, the commonest
cause of COPD, leads to increased generation of reactive oxygen species (ROS), decreased mitochondrial
ability to handle these ROS, and cell death, with the latter leading to breakdown of alveolar surfaces, blebbing,
and decreased pulmonary surface for adequate oxygen exchange. Cilia are tubulin-containing hair-like
projections on the cell surface of epithelial cells lining the tracheobronchial tree that beat in a coordinated,
metachronal wave to sweep inhaled pollutants and pathogens away from the lungs. In COPD, these cilia are
sparse, stunted, and beat with lower frequencies than in healthy lungs leading to poor mucociliary clearance
(MCC) and recurrent infections. Mitochondrial dysfunction due to overwhelming ROS production is also
associated with defective cilia formation. Our prior work led to identification of a 12-amino acid peptide that we
termed Cardiac Targeting Peptide due to its ability to transduce normal mouse heart tissue after peripheral
injection. An alanine scan with sequential, single alanine substitutions led to the discovery of two alanine
mutants (S7A and R11A with serine at position 7 and arginine at position 11 substituted with alanine) that
instead of the heart robustly transduced lung epithelial tissue after a peripheral injection. A key player in
ciliogenesis is Notch, a transcription factor that determines pluripotent Club cell fate and differentiation into
mucus producing goblet cells at the expense of multi-ciliated cells. We have shown that treatment of reciliating
mouse tracheal and human nasal epithelial cell cultures with 2nM DAPT (N-[N-(3,5-Difluorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester), a small molecule Notch inhibitor, led to significant increase in degree of
ciliogenesis, cilia length, and ciliary beat frequency compared to controls. In this grant, we are proposing to
develop these novel lung targeting peptides as vectors to deliver a number of different ROS scavengers
(Szeto-Schiller peptide, Mitotempo, reduced glutathione) to lungs of mice with smoke-induced COPD. We are
also proposing to utilize DAPT in vivo in these mice to improve ciliary function with the ultimate goal of
improving MCC. Our overarching goal is to target novel pathophysiological pathways in COPD by enhancing
mitochondrial function and ciliogenesis to improve MCC.
慢性阻塞性肺疾病(COPD)的特点是气流阻塞,粘液增多
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maliha Zahid其他文献
Maliha Zahid的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maliha Zahid', 18)}}的其他基金
Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease
针对潜在的病理生理机制开发慢性阻塞性肺病的新疗法
- 批准号:
10739195 - 财政年份:2022
- 资助金额:
$ 58.39万 - 项目类别:
Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease
针对潜在的病理生理机制开发慢性阻塞性肺病的新疗法
- 批准号:
10617756 - 财政年份:2022
- 资助金额:
$ 58.39万 - 项目类别:
Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease
针对潜在的病理生理机制开发慢性阻塞性肺病的新疗法
- 批准号:
10407568 - 财政年份:2020
- 资助金额:
$ 58.39万 - 项目类别:
Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease
针对潜在的病理生理机制开发慢性阻塞性肺病的新疗法
- 批准号:
10026871 - 财政年份:2020
- 资助金额:
$ 58.39万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 58.39万 - 项目类别:
Continuing Grant














{{item.name}}会员




